Home » Topics » Regulatory

Regulatory
RSS

FDA approves Merck & Co.'s Delstrigo and Pifeltro for the treatment of HIV-1

Aug. 31, 2018

European Commission approves Onpattro for hATTR with polyneuropathy

Aug. 31, 2018

FDA approves Jivi for hemophilia A

Aug. 31, 2018

Virus-based vaccine shows promise as candidate for Zika virus

Aug. 30, 2018

Inovelon receives marketing authorisation extension in Europe

Aug. 29, 2018

FDA approves Xerava to treat complicated intra-abdominal infections

Aug. 28, 2018

Xarelto receives approval in the E.U. for the treatment of patients with artery disease

Aug. 27, 2018

FDA approves Inveltys for post-operative inflammation and pain

Aug. 24, 2018

FDA approves Diacomit for seizures associated with Dravet syndrome

Aug. 24, 2018

FDA approves Takhzyro for prevention of HAE attacks

Aug. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...